Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes Novartis Ongoing RANIBIZUMAB 4 RFB002A240 king khaled eye specialist hospital (riyadh)
Alx-Mcd-502 A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies Alexion Pharma International Sàrl. Completed N/A 4 ALX-MCD-502 King Fahad Medical City (Riyadh)
The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial King Saud University Ongoing Caffeine 4 E-15-1484 King Khalid University Hospital (Riyadh)
Effect of heparin 20 u /kg/hr. continuous infusion on central venous catheter related thrombosis in children. KAIMRC Ongoing HEPARIN 4 RC12/145 King Abdulaziz Medical City NG (Riyadh)
The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis Novartis Ongoing Fingolimod (Glienya) 4 FTY720D2404 King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh)
Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream The University of Queensland, Australia Ongoing Meropenem / Piperacillin-Tazocin 4 MED0313 King Fahad Specialist Hospital (Dammam)
Evaluation of Changes in Quality of Life and Socio-Professional Status in Subjects with Moderate to Severe Plaque Psoriasis Treated with Adalimumab in Routine Medical Practice - EQUIPE AbbVie Completed Adalimumab 4 10241 King Faisal Specialist Hospital and Research Center (Riyadh)
XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study Bayer Ongoing Xarelto 4 16691 Prince Sultan Cardiac Center (Qassim), Abdul Rahman Al-Mishari Hospital (Riyadh), King Fahad Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh), Dallah Hospital (Riyadh), Prince Sultan Cardiac Center (Riyadh)
Monitoring of Unfractionated Heparin Therapeutic Level by Using Activated Partial Thromboplastin Time Versus Anti factor Xa Levels KAIMRC Ongoing Multiparin 4 RC15/022/R King Abdulaziz Medical City NG (Riyadh)
Impact on glycaemic control of the intensification of insulin therapy proposed by ADA/EASD guidelines with insulin glargine as pasal insulin plus a single daily dose of insulin glulisine at main meal : Basal plus strategy in real life Sanofi Ongoing Lantus®/Apidra® 4 APIDR_L_05185 King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Taif)
View 601 - 610 From 701